Qixin Yang, Jing Huang, Jiang He, Xueyang Liu, Lu Yu, Yuehua Li
Department of Urology, University-Town Hospital of Chongqing Medical University, Chongqing, 401331, P.R. China.
Department of Rehabilitation, University-Town Hospital of Chongqing Medical University, Chongqing, 401331, P.R. China.
BioData Min. 2024 Nov 14;17(1):51. doi: 10.1186/s13040-024-00404-x.
Regulatory T cells (Tregs) play a critical role in shaping the immunosuppressive microenvironment within tumors. Investigating the role of Tregs in Clear cell renal cell carcinoma (ccRCC) is crucial for identifying prognostic markers and therapeutic targets for ccRCC.
Weighted gene co-expression network analysis (WGCNA) was utilized to pinpoint modules related to Treg infiltration in TCGA-KIRC samples. Following this, consensus clustering was employed to derive two clusters associated with Treg infiltration in ccRCC. A prognostic model was then developed using the gene module associated with Treg infiltration. We then evaluated the ability of the prognostic model to predict ccRCC overall survival and demonstrated that RCN1 can be used as a target to predict ccRCC prognosis.
We deduce that the two clusters associated with Treg infiltration exhibit distinct compositions of the immune microenvironment, pathway activations, prognosis, and drug sensitivities commonly utilized in ccRCC treatment. Furthermore, a 7-gene model risk score, developed based on ccRCC Treg infiltration, proved to be a reliable prognostic marker in both training and validation cohorts. Additionally, survival analysis indicated that RCN1 serves as a reliable prognostic factor for ccRCC. Single-cell sequencing analysis revealed that RCN1 is predominantly expressed in tumor cells. A pan-cancer analysis highlighted that RCN1 is linked with poor prognosis and the activation of inflammatory response pathways across various cancers.
We developed a prognostic model associated with Treg infiltration, which facilitates the clinical categorization of ccRCC progression. Moreover, our findings underscore the significant potential of RCN1 as a ccRCC biomarker.
调节性T细胞(Tregs)在塑造肿瘤内免疫抑制微环境中起关键作用。研究Tregs在透明细胞肾细胞癌(ccRCC)中的作用对于确定ccRCC的预后标志物和治疗靶点至关重要。
利用加权基因共表达网络分析(WGCNA)来确定TCGA-KIRC样本中与Treg浸润相关的模块。在此之后,采用共识聚类法得出与ccRCC中Treg浸润相关的两个聚类。然后使用与Treg浸润相关的基因模块建立一个预后模型。我们随后评估了该预后模型预测ccRCC总生存期的能力,并证明RCN1可用作预测ccRCC预后的靶点。
我们推断,与Treg浸润相关的两个聚类表现出不同的免疫微环境组成、通路激活、预后以及ccRCC治疗中常用的药物敏感性。此外,基于ccRCC Treg浸润建立的7基因模型风险评分在训练和验证队列中均被证明是一个可靠的预后标志物。此外,生存分析表明RCN1是ccRCC的可靠预后因素。单细胞测序分析显示RCN1主要在肿瘤细胞中表达。泛癌分析强调RCN1与多种癌症的不良预后和炎症反应通路激活有关。
我们建立了一个与Treg浸润相关的预后模型,这有助于ccRCC进展的临床分类。此外,我们的研究结果强调了RCN1作为ccRCC生物标志物的巨大潜力。